Mathematical modeling of hepatitis B virus infection for antiviral therapy using LHAM

被引:4
|
作者
Aniji, M. [1 ]
Kavitha, N. [2 ]
Balamuralitharan, S. [3 ]
机构
[1] Univ Coll Engn, Pattukkottai 614701, Tamil Nadu, India
[2] Univ Coll Engn, Dept Math, Pattukkottai 614701, Tamil Nadu, India
[3] SRM Inst Sci & Technol, Fac Engn & Technol, Dept Math, Kattankulathur 603203, Tamil Nadu, India
关键词
HBV; Antiviral therapy; LHAM; CTL; Immune; Mathematical modeling; 34G20; 34A34; HBV; TRANSMISSION; DYNAMICS; EPIDEMIOLOGY; VACCINATION; PREVALENCE;
D O I
10.1186/s13662-020-02770-2
中图分类号
O29 [应用数学];
学科分类号
070104 ;
摘要
Anti-viral therapy is comparatively very effective for patients who get affected by the hepatitis B virus. It is of prime importance to understand the different relations among the viruses, immune responses and overall health of the liver. In this paper, mathematical modeling is done to analyze and understand the effect of antiviral therapy using LHAM which describes the possible relation to HBV and target liver cells. The numerical simulations and error analysis are done up to a sixth-order approximation with the help of Matlab. This paper analyzes how the number of infected cells largely gets reduced and also how the liver damage can be controlled. Therefore, the treatment is successful for HBV infected patients.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Mathematical modeling of hepatitis B virus infection for antiviral therapy using LHAM
    M. Aniji
    N. Kavitha
    S. Balamuralitharan
    Advances in Difference Equations, 2020
  • [2] Approximate solutions for HBV infection with stability analysis using LHAM during antiviral therapy
    M. Aniji
    N. Kavitha
    S. Balamuralitharan
    Boundary Value Problems, 2020
  • [3] Approximate solutions for HBV infection with stability analysis using LHAM during antiviral therapy
    Aniji, M.
    Kavitha, N.
    Balamuralitharan, S.
    BOUNDARY VALUE PROBLEMS, 2020, 2020 (01)
  • [4] Disease Progression Mathematical Modeling With a Case Study on Hepatitis B Virus Infection
    Boivin-Champeaux, Clemence
    Velez de Mendizabal, Nieves
    Jones, Aksana
    Balsitis, Scott
    Schmidt, Stephan
    Feigelman, Justin S.
    Azeredo, Francine Johansson
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2025, 14 (03): : 420 - 434
  • [5] Antiviral therapy and resistance with hepatitis B virus infection
    Hans L Tillmann
    World Journal of Gastroenterology, 2007, (01) : 125 - 140
  • [6] Antiviral therapy and resistance with hepatitis B virus infection
    Tillmann, Hans L.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (01) : 125 - 140
  • [7] Antiviral Therapy of Liver Cirrhosis Related to Hepatitis B Virus Infection
    Lu, Lun-Gen
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2014, 2 (03) : 197 - 201
  • [8] New antiviral agents for the therapy of chronic hepatitis B virus infection
    Zoulim, F
    Trepo, C
    INTERVIROLOGY, 1999, 42 (2-3) : 125 - 144
  • [9] Association of gestational hepatitis B virus infection and antiviral therapy with pregnancy outcomes: A retrospective study
    Mao, Kaiyi
    Jiang, Pingying
    Cai, Weiqi
    Lin, Yongxu
    Zhou, Yu
    Li, Dan
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2024, 166 (01) : 115 - 125
  • [10] Antiviral therapy for hepatitis B virus infection is beneficial for the prognosis hepatocellular carcinoma
    Wan, Hui
    Zhang, Yu-Xin
    Shan, Guan-Yue
    Cheng, Jun-Ya
    Qiao, Duan-Rui
    Liu, Yi-Ying
    Shi, Wen-Na
    Li, Hai-Jun
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2025, 17 (01)